As COVAXIN is under restricted use for emergency situations and under the clinical trial mode, every participant who receives this vaccine is being given three documents along with the vaccine shot. A fact sheet in all regional languages that describes the vaccine and who is eligible to receive it, an informed consent sheet that the recipients are expected to sign, and a form for filling in details of any adverse events following immunisation.
The form for AEFI has to be filled by the beneficiaries after a designated doctor calls them daily for seven days as follow up to check for any side effects after immunisation.
